Severe dry eye disease (DED) affects the productivity and quality of life of millions of people. Prompted by the prevalence of this chronic condition, many pharmaceutical companies have set out in search of more robust treatments. Solutions have thus far…

Taipei, Taiwan, 23 rd June 2022 / BRIM Biotechnology, Inc. (BRIM, TPEx 6885) enters the Emerging Stock Market (ESM) in Taiwan on 23 rd June 2022, CST. The news was announced at the company’s first earnings call on 22 nd…

Success doesn’t just come from a winning idea or an exciting new concept.  Success comes from having a dedicated team behind that idea, with the enthusiasm and commitment to drive it from concept to clinic. The people behind the peptide…